Literature DB >> 6894680

[The utilization of small repeated doses of iodine 131 in the treatment of Graves' disease. Results (author's transl)].

J L Latapie, G Lefort, M Commenges, P Roger, L J Riviere, L Mauriac.   

Abstract

In graves' disease small amounts of radioactive iodine administered repeatedly on a monthly basis depending on the progress of the disease is a method whose effectiveness we have studied on 192 cases over a period of 3 to 7 years. Relapses (4 %), failures (11 %) permanent hypothyroidism (24 % after 7 years) and the duration of the active stage have been collated with different clinical or biological parameters in order better to define the main factors that determine the course and prognosis. The size of the goitre and the presence of antithyroglobulin antibodies are among the most significant.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6894680

Source DB:  PubMed          Journal:  Ann Endocrinol (Paris)        ISSN: 0003-4266            Impact factor:   2.478


  2 in total

1.  A reappraisal of the role of methimazole and other factors on the efficacy and outcome of radioiodine therapy of Graves' hyperthyroidism.

Authors:  C Marcocci; D Gianchecchi; I Masini; F Golia; C Ceccarelli; E Bracci; G F Fenzi; A Pinchera
Journal:  J Endocrinol Invest       Date:  1990-06       Impact factor: 4.256

2.  The Incidence of Hypothyroidism Following the Radioactive Iodine Treatment of Graves' Disease and the Predictive Factors Influencing its Development.

Authors:  Maha Abd El-Kareem El-Sayed Husseni
Journal:  World J Nucl Med       Date:  2016 Jan-Apr
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.